dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | González Albarrán, Olga |
dc.contributor.author | Morales, Cristóbal |
dc.contributor.author | Pérez-Maraver, Manuel |
dc.contributor.author | Aparicio-Sánchez, José Juan |
dc.contributor.author | Simó Canonge, Rafael |
dc.date.accessioned | 2022-09-12T08:30:05Z |
dc.date.available | 2022-09-12T08:30:05Z |
dc.date.issued | 2022-07 |
dc.identifier.citation | González-Albarrán O, Morales C, Pérez-Maraver M, Aparicio-Sánchez JJ, Simó R. Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D. Diabetes Ther. 2022 Jul;13(Suppl 1):35–49. |
dc.identifier.issn | 1869-6961 |
dc.identifier.uri | https://hdl.handle.net/11351/8140 |
dc.description | Albuminúria; Malaltia renal diabètica; Diabetis tipus 2 |
dc.description.sponsorship | AstraZeneca funded the writing assistance provided by Springer Healthcare Ibérica SL and the journal’s Rapid Service Fee. This supplement has been sponsored by AstraZeneca. |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Diabetes Therapy;13(Supl 1) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Diabetis no-insulinodependent - Complicacions |
dc.subject | Fetge - Càncer - Tractament |
dc.subject.mesh | Diabetes Mellitus, Type 2 |
dc.subject.mesh | /complications |
dc.subject.mesh | Kidney Diseases |
dc.subject.mesh | /therapy |
dc.title | Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s13300-022-01276-2 |
dc.subject.decs | diabetes mellitus tipo II |
dc.subject.decs | /complicaciones |
dc.subject.decs | enfermedades renales |
dc.subject.decs | /terapia |
dc.relation.publishversion | https://doi.org/10.1007/s13300-022-01276-2 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [González-Albarrán O] Endocrinology and Nutrition Department, Gregorio Marañón Hospital, Madrid, Spain. [Morales C] Endocrinology and Nutrition Department, Virgen Macarena Hospital, Seville, Spain. Hospital Vithas Sevilla, Seville, Spain. [Pérez-Maraver M] Endocrinology and Nutrition Unit, Bellvitge University Hospital-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. [Aparicio-Sánchez JJ] Medical Affairs Department, AstraZeneca Farmacéutica Spain, Madrid, Spain. [Simó R] Diabetes and Metabolism Research Group, VHIR, Endocrinology Department, Vall d’Hebron University Hospital, Autonomous University Barcelona, 08035, Barcelona, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain |
dc.identifier.pmid | 35704167 |
dc.identifier.wos | 000811438400003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |